Vimarsana
Biggest News Aggregation in the World

Page 9 - Statement Regarding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Statement Regarding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Statement Regarding Today - Breaking & Trending Today

Rare Earth Breaking News - Defense Metals (TSX-V: DEFN.V) (OTCQB: DFMTF) Appoints Guy de Selliers de Moranville to the Board of Directors - Vimarsana News

Rare Earth Breaking News - Defense Metals (TSX-V: DEFN.V) (OTCQB: DFMTF) Appoints Guy de Selliers de Moranville to the Board of Directors

Rare Earth Breaking News - Defense Metals (TSX-V: DEFN.V) (OTCQB: DFMTF) Appoints Guy de Selliers de Moranville to the Board of Directors

Ultra Lithium Provides Bi-Weekly Default Status Report - Vimarsana News

Ultra Lithium Provides Bi-Weekly Default Status Report

Ultra Lithium Inc. is providing this bi-weekly default status report in accordance with National Policy 12-203 Management Cease Trade Orders . On March 4, 2024, the Company announced that effective February 29, 2024 it has been granted a voluntary... - Veroeffentlicht am 03.04.2024

FTC, DOJ, And HHS Launch Cross-Government Inquiry On Private Equity Investment In Healthcare - Healthcare - Vimarsana News

FTC, DOJ, And HHS Launch Cross-Government Inquiry On Private Equity Investment In Healthcare - Healthcare

On March 5, 2024, the Department of Justice ("DOJ"), the Federal Trade Commission ("FTC"), and Department of Health and Human Services ("HHS," together the "Agencies")...

Source: mondaq.com
FTC And DOJ Target Healthcare And Life Sciences Industries - Antitrust, EU Competition - Vimarsana News

FTC And DOJ Target Healthcare And Life Sciences Industries - Antitrust, EU Competition

The healthcare industry remains a focal point of President Biden's antitrust agenda.

Source: mondaq.com
Defence's Successful Results on Its AccuTOX Anti-Cancer ARM Vaccine Creates a Potent Second-Generation Anti-Cancer ARM-002 Vaccine - Vimarsana News

Defence's Successful Results on Its AccuTOX Anti-Cancer ARM Vaccine Creates a Potent Second-Generation Anti-Cancer ARM-002 Vaccine

Defence Therapeutics Inc. , a Canadian biotechnology company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce the successful testing of a...